Last reviewed 2026-04-20 · How we verify

PN 200

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Headache
• Nausea
• Acneiform Eruption
• Sore throat
• Nasal Congestion
• Folliculitis
• Herpes Labialis

Key clinical trials

• Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin (PHASE2)
• Effects of Parenteral and Enteral Nutrition on Skeletal Muscle Genomics (NA)
• Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 ) (PHASE2)
• Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck (PHASE3)
• Effects of Early Short-term Intravenous Iron Supplements Combined EPO in Preterm Infants (PHASE4)
• Perineural Versus IV Dexmedetomidine as Adjuvant to Quadratus Lamborum Block for Pediatrics Undergoing Pyeloplasty (EARLY_PHASE1)
• Effects of Konjac Glucomannan Noodle Intervention in Subjects With Metabolic Syndrome (NA)
• Oral Nutrition After Regular Radical Cystectomy (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• PN 200 CI brief — competitive landscape report
• PN 200 updates RSS · CI watch RSS
• POZEN portfolio CI